Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry C Pitot

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 25, 2020
Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancerDaniel S Childs, Harry H Yoon, Rachel A Eiring, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronideCheri Enders Klein, Elora Gupta, Joel M Reid, et al.
Cancer|September 29, 2011
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancerPhilip A Philip, Michelle R Mahoney, Kyle D Holen, et al.
The International Journal of Biochemistry & Cell Biology|May 22, 2003
Localization and hormonal control of serine dehydratase during metabolic acidosis differ markedly from those of phosphoenolpyruvate carboxykinase in rat kidneyTohru Masuda, Hirofumi Ogawa, Takako Matsushima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741Charles S Fuchs, Richard M Goldberg, Daniel J Sargent, et al.
Investigational New Drugs|February 19, 2008
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreasSteven Attia, Jill Kolesar, Michelle R Mahoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
Comparison of continuous versus categorical tumor measurement-based metrics to predict overall survival in cancer treatment trialsMing-Wen An, Sumithra J Mandrekar, Megan E Branda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancerPhilip A Philip, Michelle R Mahoney, Cristine Allmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Phase II study of erlotinib in patients with advanced biliary cancerPhilip A Philip, Michelle R Mahoney, Cristine Allmer, et al.
Genetics|July 9, 2004
A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of congenic linesAndrea Bilger, L Michelle Bennett, Reynaldo A Carabeo, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 25, 2020
Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancerDaniel S Childs, Harry H Yoon, Rachel A Eiring, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronideCheri Enders Klein, Elora Gupta, Joel M Reid, et al.
Cancer|September 29, 2011
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancerPhilip A Philip, Michelle R Mahoney, Kyle D Holen, et al.
The International Journal of Biochemistry & Cell Biology|May 22, 2003
Localization and hormonal control of serine dehydratase during metabolic acidosis differ markedly from those of phosphoenolpyruvate carboxykinase in rat kidneyTohru Masuda, Hirofumi Ogawa, Takako Matsushima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741Charles S Fuchs, Richard M Goldberg, Daniel J Sargent, et al.
Investigational New Drugs|February 19, 2008
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreasSteven Attia, Jill Kolesar, Michelle R Mahoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
Comparison of continuous versus categorical tumor measurement-based metrics to predict overall survival in cancer treatment trialsMing-Wen An, Sumithra J Mandrekar, Megan E Branda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancerPhilip A Philip, Michelle R Mahoney, Cristine Allmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Phase II study of erlotinib in patients with advanced biliary cancerPhilip A Philip, Michelle R Mahoney, Cristine Allmer, et al.
Genetics|July 9, 2004
A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of congenic linesAndrea Bilger, L Michelle Bennett, Reynaldo A Carabeo, et al.
Pageof 9